Friday

20th Sep 2019

Focus

Homeopathy industry pushes for EU-wide public healthcare support

  • Homeopathy remedies on sale (Photo: incurable_hippie)

With the European Commission soon to launch a review of EU pharmaceutical laws, the homeopathy industry feels the time is ripe to launch fresh lobbying push in Brussels to have the EU force all member states to provide access to the product from public health systems and loosen up the approval process for their remedies.

Representatives of the industry, practitioners and patients that use homeopathic products are to hold an EU Homeopathy Day in the European Parliament on 23 March as the kick-off for a new effort to win EU-level alternative-medicine-friendly legislation.

Read and decide

Join EUobserver today

Support quality EU news

Get instant access to all articles — and 18 year's of archives. 30 days free trial.

... or join as a group

Industry lobbyists and their MEP allies believe that with the new European Commission expected to launch a review of EU pharmaceutical laws at some point during its four-year term, now is their chance to press their case.

"It provides an excellent opportunity for positive change," Irish liberal euro-deputy Marian Harkin, the organiser of the event in the parliament, told EUobserver. "The aim is to integrate homeopathy into EU health policy,"

Homeopathy claims to heal patients with highly diluted treatments of substances that cause physical responses that are similar to the symptoms of the ailment. Invented by by German physician Samuel Hahnemann in 1796, the treatments are diluted to such a degree that nothing of the original substance is left. Its practitioners say however that the water retains a ‘memory' of the substance.

While up to 125 million Europeans, including, famously, Prince Charles, use homeopathic products every year - the water is usually dropped onto sugar pills that are then consumed - and the industry worth €1.05 billion as of 2009, reviews of all the published studies on the practice fail to demonstrate any efficacy beyond the placebo affect.

As a result, the practice is regularly pilloried by sceptics who attack it as pseudoscience and potentially dangerous if taken instead of conventional medicines such as vaccinations.

"There's always a question about the science," said Ms Harkin, "but with homeopathy, a lot of it is based on tradition and you need to be careful that the judgments that are not purely based on science. They need to be based on efficacy as well as that."

According to Nand de Herdt, the president of the European Coalition on Homeopathic and Anthroposophic Medicinal Products (Echamp), the industry lobby group based in the European capital, said they are to press for "concrete action at the EU level," and that the coming legislative review "provides a very good opportunity to do so."

Single market

The European institutions, even after passage of the Lisbon Treaty, still have very little responsibility for the health sector and until now, the European Commission has said as a result, it has very little room to manoeuvre in this area.

But this time, according to Mr de Herdt, instead of trying the health legislation route, the lobbyists will "try to leverage single market rules," where the EU has very powerful powers indeed.

In this way, Echamp and its partners hope to win a harmonisation of laws governing the authorisation of homeopathic products across the bloc. "Some people have access to some products in some member states but not in others. Patients, doctors, practitioners are being denied access to the products they choose."

Ms Harkin believes the single market angle will work: "If we look at the EU and what it's basically about, it's about ensuring the free movement of people, goods and services across the union. So from that perspective, we can get legislation in this area."

Using the same legislative crowbar, the industry lobby along with the European Central Council of Homeopaths - the professional association for practitioners, the European Committee for Homeopathy - which brings together the doctors that prescribe the sugar pills, and the European Federation of Homeopathic Patients' Associations - representing the people that swallow them, hope to require public health systems to pay for access to such treatments wherever patients demand them.

"In most member states, homeopathy is a private matter. That is to say not covered by all public health systems. But it ranges from country to country. This is a major concern. Sweden for example forbids doctors from prescribing it, while in France, it can only be prescribed by doctors."

Mr de Herdt complains that the number of homeopathic products on the market as compared to the total number of homeopathic products that could be available is far too low. They exist on the market, often sold by small outfits over the internet, but there is no legal status for these products. Unauthorised, they are tolerated by authorities.

"This is fine for a small internet business, but for serious manufacturers, this is not a good situation."

The problem is with the approving authorities, he says, "because they apply the rules that apply to chemical substances. But these are practices from a very old tradition, and authorities do not have the capacity to manage an appropriate assessment of these products."

As a result, the major push of the homeopathy lobby is to have a separate stand-alone EU directive that exempts them from regular chemical and other health and safety rules. EU legislation from 1992 lays down provisions for the licensing of homeopathic products, but Mr de Herdt says after 18 years, the laws are outdated, resulting in a "significant reduction in the number of homeopathic products on the market."

"The current system is substance-oriented. Our products need a system that is therapeutic-oriented," he said, explaining that it was not just the medicine itself but the whole process a practitioner applies that produces the result.

Research funding

Echamp meets with commission representatives "three or four times a year" and Mr de Herdt says that the EU executive is on side with most of their arguments already, but that the changes they are looking for are for the moment "not at the top of their priorities."

"On the level of the therapeutic argument, research projects, we've had a lot of success, but in terms of product authorisation, the success so far has been more limited."

On 16 March, the new European Parliament Intergroup on Complimentary and Alternative Medicine is to have its founding meeting. The work programme of this initiative, an alliance of MEPs and "a consortium of European homeopathic patients and doctors", is to focus on "improving access, availability and choice."

Already, in 2006, the chamber amended the Seventh Community Framework Research Programme (FP7), the EU's main instrument for funding scientific research, to include ‘complementary medicine' and in 2007, the parliament similarly amended the Second Programme of Community Action in the Field of Health, the bloc's funding mechanism for public-health-related projects.

Then in October 2009, the EU awarded a grant of €1.5 million for a 36-month research project carried out by the Communication Platform on topics related to Complementary and Alternative Medicine in Europe (CAMbrella), a Munich-based, 12-member-state research network whose advisory board includes alternative medicine practitioners and product manufacturers. The project's remit includes a review of the current legal status and policies governing alternative medicine provision in the EU.

UK parliament committee: 'Just a placebo'

The lobby's fresh push for EU homeopathy rules comes just as the UK readies itself to strip provision of homeopathic medicine from the country's National Health Service. On 22 February, the influential Scientific Committee of the House of Commons slammed the practice, saying there was no evidence that it provides anything more than the placebo effect and that manufacturers must stop making medical claims for their products.

Andy Lewis, the proprietor of the Quackometer website, which debunks quack medicine on the internet, said that the new campaign of European homeopathy lobby was at odds with the British parliament's enquiry.

"The MPs concluded, after a very detailed review of the evidence, that homeopathy was scientifically implausible and could not be shown to be effective," said Mr Lewis, who was also one of the organisers of a series of ‘homeopathy overdose' demonstrations outside pharmacists across the UK in January in which sceptics swallowed entire bottles of homeopathy sugar pills. "The recommendation was that homeopathy should not be publicly funded and that medicines labeling regulations should not allow it to make unfounded claims. "

"The EU would be failing its citizens, and pandering to business interests, if it allowed homeopathy sugar pill manufacturers to make misleading claims about this discredited 18th Century quackery," he added.

Ms Harkin, for her part, is familiar with such criticism, but dismisses it as in the service of Big Pharma: "There are those that believe that only those medicines prescribed by doctors and manufactured by Pfizer will make you well, but a lot of ordinary people do not subscribe to that view."

"[The sceptics] are saying medicines must be judged by one critierion only, that it satisfies a scientific equation. Whereas there are many standards by which medicines should be judged," she said.

"The agenda is to say that science has the answer to everything. Well, they should have learnt by now that it hasn't."

Exclusive

Belgium prepares probe into Politico tobacco sponsorship

Tobacco company British American Tobacco sponsored the popular Playbook newsletter this week - saying it is not against the law because the advertisements were not about specific products. Now the Belgian authorities are preparing to investigate.

Investigation

The most dangerous pesticide you've never heard of

Scientists say there is no acceptable dose to avoid brain damage. Its use is banned in several European countries. Yet its residues are found in fruit baskets, on dinner plates, and in human urine samples from all over Europe.

Allergic disease and asthma on the rise in Europe

The number of Europeans with allergies has been growing extensively since the mid-1950s. Although some European countries have reached a peak, the overall number of citizens with allergic diseases continues to grow.

News in Brief

  1. Austria to veto EU trade deal with South America
  2. Brexit minister asks EU for 'flexibility' to secure a deal
  3. Kovesi has 'sufficient majority' for prosecutor post
  4. France, Finland give UK ultimatum for Brexit plan
  5. Minsk talks bode ill for EU's peace summit on Ukraine
  6. Poll: Poland's nationalist rulers to win October election
  7. Irish lawyers clash with EU commission in Apple case
  8. NGOs take aim at EU smartphone pollution

Opinion

A fundamental contradiction in EU drug policy

The knock-on affects from a 'war on drugs' in Europe is creating problems in Albania - and as far afield as Guinea-Bissau, Mali, Bangladesh and the Philippines.

Supported by

Stakeholders' Highlights

  1. Nordic Council of MinistersNew programme studies infectious diseases and antibiotic resistance
  2. UNESDAUNESDA reduces added sugars 11.9% between 2015-2017
  3. International Partnership for Human RightsEU-Uzbekistan Human Rights Dialogue: EU to raise key fundamental rights issues
  4. Nordic Council of MinistersNo evidence that social media are harmful to young people
  5. Nordic Council of MinistersCanada to host the joint Nordic cultural initiative 2021
  6. Vote for the EU Sutainable Energy AwardsCast your vote for your favourite EUSEW Award finalist. You choose the winner of 2019 Citizen’s Award.
  7. Nordic Council of MinistersEducation gets refugees into work
  8. Counter BalanceSign the petition to help reform the EU’s Bank
  9. UNICEFChild rights organisations encourage candidates for EU elections to become Child Rights Champions
  10. UNESDAUNESDA Outlines 2019-2024 Aspirations: Sustainability, Responsibility, Competitiveness
  11. Counter BalanceRecord citizens’ input to EU bank’s consultation calls on EIB to abandon fossil fuels
  12. International Partnership for Human RightsAnnual EU-Turkmenistan Human Rights Dialogue takes place in Ashgabat

Latest News

  1. Malta PM accused of 'blackmail' over slain reporter
  2. Diplomats back Romania's Kovesi for EU top prosecutor
  3. Brexit raises questions for EU defence integration
  4. Low-carbon cities can unlock €21tn by 2050, report finds
  5. France, Italy want 'automatic' distribution of migrants
  6. Europe's refugee policy is test of its true 'way of life'
  7. A new Commission for the one percent
  8. Juncker: No-deal Brexit 'palpable'

Stakeholders' Highlights

  1. Nordic Council of MinistersNew campaign: spot, capture and share Traces of North
  2. Nordic Council of MinistersLeading Nordic candidates go head-to-head in EU election debate
  3. Nordic Council of MinistersNew Secretary General: Nordic co-operation must benefit everybody
  4. Platform for Peace and JusticeMEP Kati Piri: “Our red line on Turkey has been crossed”
  5. UNICEF2018 deadliest year yet for children in Syria as war enters 9th year
  6. Nordic Council of MinistersNordic commitment to driving global gender equality
  7. International Partnership for Human RightsMeet your defender: Rasul Jafarov leading human rights defender from Azerbaijan
  8. UNICEFUNICEF Hosts MEPs in Jordan Ahead of Brussels Conference on the Future of Syria
  9. Nordic Council of MinistersNordic talks on parental leave at the UN
  10. International Partnership for Human RightsTrial of Chechen prisoner of conscience and human rights activist Oyub Titiev continues.
  11. Nordic Council of MinistersNordic food policy inspires India to be a sustainable superpower
  12. Nordic Council of MinistersMilestone for Nordic-Baltic e-ID

Stakeholders' Highlights

  1. Counter BalanceEU bank urged to free itself from fossil fuels and take climate leadership
  2. Intercultural Dialogue PlatformRoundtable: Muslim Heresy and the Politics of Human Rights, Dr. Matthew J. Nelson
  3. Platform for Peace and JusticeTurkey suffering from the lack of the rule of law
  4. UNESDASoft Drinks Europe welcomes Tim Brett as its new president
  5. Nordic Council of MinistersNordic ministers take the lead in combatting climate change
  6. Counter BalanceEuropean Parliament takes incoherent steps on climate in future EU investments
  7. International Partnership For Human RightsKyrgyz authorities have to immediately release human rights defender Azimjon Askarov
  8. Nordic Council of MinistersSeminar on disability and user involvement
  9. Nordic Council of MinistersInternational appetite for Nordic food policies
  10. Nordic Council of MinistersNew Nordic Innovation House in Hong Kong
  11. Nordic Council of MinistersNordic Region has chance to become world leader when it comes to start-ups
  12. Nordic Council of MinistersTheresa May: “We will not be turning our backs on the Nordic region”

Join EUobserver

Support quality EU news

Join us